Sara Lorente

964 total citations
24 papers, 518 citations indexed

About

Sara Lorente is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Sara Lorente has authored 24 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 12 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Sara Lorente's work include Liver Disease and Transplantation (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Sara Lorente is often cited by papers focused on Liver Disease and Transplantation (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Sara Lorente collaborates with scholars based in Spain, United Kingdom and United States. Sara Lorente's co-authors include Trinidad Serrano, Alberto Luè, Agustín Garcia‐Gil, Pedro M. Baptista, Bruno Sangro, Juan Ignacio Arenas, Mercedes Iñarrairaegui, Milagros Testillano, Miguel Montoro and Angel I. Lanas and has published in prestigious journals such as Gut, Transplantation and American Journal of Transplantation.

In The Last Decade

Sara Lorente

21 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Lorente Spain 12 290 263 155 72 68 24 518
Frans van der Heide Netherlands 11 214 0.7× 277 1.1× 257 1.7× 26 0.4× 104 1.5× 19 533
Vikram Raut India 11 271 0.9× 296 1.1× 111 0.7× 79 1.1× 60 0.9× 22 405
Armando Ganoza United States 12 151 0.5× 294 1.1× 111 0.7× 113 1.6× 81 1.2× 50 482
G.A. Makar United States 14 341 1.2× 265 1.0× 326 2.1× 54 0.8× 64 0.9× 33 636
Richard Mimeault Canada 12 252 0.9× 556 2.1× 70 0.5× 139 1.9× 152 2.2× 29 783
John A. Donovan United States 8 320 1.1× 222 0.8× 280 1.8× 44 0.6× 27 0.4× 10 502
Naotaka Hashimoto Japan 15 471 1.6× 382 1.5× 275 1.8× 61 0.8× 35 0.5× 36 622
Andreas G. Tzakis United States 11 228 0.8× 321 1.2× 94 0.6× 106 1.5× 60 0.9× 20 531
Elizabeth Coss United States 7 241 0.8× 501 1.9× 196 1.3× 71 1.0× 19 0.3× 15 674
Minoru Umehara Japan 12 254 0.9× 337 1.3× 94 0.6× 29 0.4× 48 0.7× 59 458

Countries citing papers authored by Sara Lorente

Since Specialization
Citations

This map shows the geographic impact of Sara Lorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Lorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Lorente more than expected).

Fields of papers citing papers by Sara Lorente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Lorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Lorente. The network helps show where Sara Lorente may publish in the future.

Co-authorship network of co-authors of Sara Lorente

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Lorente. A scholar is included among the top collaborators of Sara Lorente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Lorente. Sara Lorente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matilla, Ana, Marı́a Varela, Mercedes Iñarrairaegui, et al.. (2025). Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial. Journal of Patient-Reported Outcomes. 9(1). 39–39.
2.
Matilla, Ana, Marı́a Varela, Mercedes Iñarrairaegui, et al.. (2022). Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study. Journal for ImmunoTherapy of Cancer. 10(11). e005457–e005457. 48 indexed citations
3.
Rodríguez‐Perálvarez, Manuel, Jordi Colmenero, Antonio González, et al.. (2022). Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation. American Journal of Transplantation. 22(6). 1671–1682. 59 indexed citations
4.
Serrablo, Alejandro, Alberto Luè, Sara Lorente, et al.. (2022). How Donor and Surgical Factors Affect the Viability and Functionality of Human Hepatocytes Isolated From Liver Resections. Frontiers in Medicine. 9. 875147–875147. 4 indexed citations
5.
Serrano, Trinidad, Luis Esteban, Marina Berenguer, et al.. (2022). Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort. Transplant International. 35. 10263–10263. 30 indexed citations
6.
Luè, Alberto, Elena Martinez, Mercedes Navarro, et al.. (2019). Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation. Transplantation. 103(8). e211–e215. 10 indexed citations
7.
Puigvehí, Marc, María‐Carlota Londoño, Xavier Torras, et al.. (2019). Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV–cirrhotic patients. Journal of Gastroenterology. 55(2). 205–216. 18 indexed citations
8.
Herrero, Ignacio, Manuel de la Mata, Trinidad Serrano, et al.. (2016). Controlling Diabetes After Liver Transplantation. Transplantation. 100(10). e66–e73. 13 indexed citations
9.
Luè, Alberto, et al.. (2016). How important is donor age in liver transplantation?. World Journal of Gastroenterology. 22(21). 4966–4966. 77 indexed citations
10.
Blas, Ignacio de, et al.. (2016). Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patients. Clinical Biochemistry. 49(7-8). 560–565. 10 indexed citations
11.
Rosa, Pedro Antonio de la, Alberto Luè, Trinidad Serrano, et al.. (2016). A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib. Liver International. 36(8). 1206–1212. 49 indexed citations
12.
Castiella, Tomás, Sara Lorente, Francisco A. García‐Gil, et al.. (2014). Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation. European Journal of Gastroenterology & Hepatology. 26(8). 871–879. 10 indexed citations
13.
Lorente, Sara, et al.. (2011). Liver Transplanted Patients With Donors Older Than 60 Years Require More Hospital Resources. Transplantation Proceedings. 43(3). 735–736. 2 indexed citations
14.
Lorente, Sara & Miguel Montoro. (2007). Colestasis gravídica. Gastroenterología y Hepatología. 30(9). 541–547. 7 indexed citations
15.
Lanas, Ángel, Luı́s Rodrigo, José Luis Márquez, et al.. (2003). Low Frequency of Upper Gastrointestinal Complications in a Cohort of High-Risk Patients Taking Low-Dose Aspirin or NSAIDS and Omeprazole. Scandinavian Journal of Gastroenterology. 38(7). 693–700. 42 indexed citations
16.
17.
Lorente, Sara, et al.. (2002). Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut. 50(1). 13–18. 54 indexed citations
18.
Lorente, Sara, et al.. (2000). Paraganglioma extraadrenal retroperitoneal. Presentación de dos nuevos casos. 67(1). 110–113. 2 indexed citations
19.
Lorente, Sara, et al.. (1999). [Recurrent digestive hemorrhage as a complication of an intraduodenal diverticulum].. PubMed. 22(6). 282–5. 3 indexed citations
20.
Serrano, Trinidad, Angel I. Lanas, Sara Lorente, & Raquel Sainz. (1997). Cytokine effects on pepsinogen secretion from human peptic cells.. Gut. 40(1). 42–48. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frans van der Heide Breakdown of academic impact, for papers by Vikram Raut Breakdown of academic impact, for papers by Armando Ganoza Breakdown of academic impact, for papers by G.A. Makar Breakdown of academic impact, for papers by Richard Mimeault Breakdown of academic impact, for papers by John A. Donovan Breakdown of academic impact, for papers by Naotaka Hashimoto Breakdown of academic impact, for papers by Andreas G. Tzakis Breakdown of academic impact, for papers by Elizabeth Coss Breakdown of academic impact, for papers by Minoru Umehara
Rankless by CCL
2026